Industry Overview
Artificial Intelligence (AI) in cardiology market is growing at a CAGR of 19.5% during the forecast period (2025-2035). AI and machine learning are transforming cardiac imaging, diagnosis, and treatment planning. It provides early detection, risk prediction, and personalized treatment approaches by examining large amounts of data.
The AI in cardiology market demonstrates a high level of innovation, driven by developments in deep learning, machine learning, cloud computing, big data analytics, and other emerging technologies. For instance, in May 2024, InfoBionic.AI partnered with HBox.AI to develop a next-generation cardiovascular care model, combining InfoBionic.AI’s advanced cardiac telemetry with HBox.AI’s virtual care platform to deliver AI-powered remote monitoring, virtual consultations, and diagnostic care.
For Full Report Description + Research Methodology + Table of Contents + Infographics @
https://ai.omrglobal.com/report-gallery/artificial-intelligence-ai-in-cardiology-market/
Recent Developments
- In May 2025, Anumana broadened its AI platform to include entire cardiovascular care, extending beyond diagnostic ECG-AI technology, into perioperative and acute cardiac care. The company is advancing on generative AI imaging and visualization technologies to improve heart patient outcomes.
- In March 2025, Fujifilm partnered with Us2.AI to bring AI automation to echocardiography. The partnership combines Us2.AI’s analysis powered by AI and Fujifilm’s LISENDO 800 Ultrasound System to provide fully automated assessments of heart chambers.
- In February 2025, Cardio Diagnostics Holdings, Inc. partnered with seven new provider organizations to increase the reach of its AI-based precision cardiovascular medicine tests, including Epi+Gen CHD and PrecisionCHD. This allows the company to revolutionize the detection, prevention, and management of coronary heart disease.
Some of the Key Companies in the Artificial Intelligence in Cardiology Market include-
- Abbott Laboratories
- AliveCor, Inc.
- Bardy Diagnostics, Inc.
- Biofourmis Inc.
- CardiAI
- Cleerly, Inc.
- Dia Imaging Analysis Ltd.
- GE HealthCare Technologies Inc.
- HeartFlow, Inc.
- HeartVista Inc.
- IDOVEN
- iRhythm Technologies, Inc.
- Koninklijke Philips N.V.
- Medtronic Plc
- RSIP Vision
- Siemens Healthineers co.
- TempusAI, Inc.
- UltraSight Inc.
- Ultromics Ltd
- ai, Inc.
Artificial Intelligence in Cardiology Market Segmentation Analysis
Global Artificial Intelligence in Cardiology Market by Component
- Software
- Services
Global Artificial Intelligence in Cardiology Market by Application
- Cardiac Arrhythmias
- Stroke
- Ischemic Heart Disease /CAD
- Others (Electrophysiology (EP) Procedures, and Cardiac Risk Assessment)
Global Artificial Intelligence in Cardiology Market by End-user
- Life Science Companies
- Healthcare Payers
- Healthcare Providers
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- ASEAN Economies (Singapore, Thailand, Vietnam, Indonesia, and Other)
- Australia and New Zealand
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- Middle East and Africa
Anurag Tiwari
Director Sales Division
+91 780-304-0404
info@omrglobal.com
Visit us on social media:
Facebook | X | LinkedIn